November 26, 2012 / 7:55 AM / 5 years ago

India's Ranbaxy launches acne drug in US

(Reuters) - Ranbaxy Laboratories Ltd, India's top drugmaker by sales, said it has launched Absorica, a drug used to treat recalcitrant acne, in the United States.

The drug is in-licensed from Cipher Pharmaceuticals Inc, said Ranbaxy, controlled by Japan's Daiichi Sankyo Co, on Monday.

Reporting by Kaustubh Kulkarni in Mumbai

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below